This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Canine TNF-alpha DuoSet ELISA
catalog :
DY1507
quantity :
1 Kit (for 15 Plates)
price :
850 USD
citations: 17
Reference
Chow L, Wheat W, Ramirez D, Impastato R, Dow S. Direct comparison of canine and human immune responses using transcriptomic and functional analyses. Sci Rep. 2024;14:2207 pubmed publisher
Costa S, Soares M, Poleto Bragato J, Dos Santos M, Rebech G, de Freitas J, et al. MicroRNA-194 regulates parasitic load and IL-1β-dependent nitric oxide production in the peripheral blood mononuclear cells of dogs with leishmaniasis. PLoS Negl Trop Dis. 2024;18:e0011789 pubmed publisher
Rebech G, Bragato J, Costa S, de Freitas J, Dos Santos M, Soares M, et al. miR-148a regulation interferes in inflammatory cytokine and parasitic load in canine leishmaniasis. PLoS Negl Trop Dis. 2023;17:e0011039 pubmed publisher
Bragato J, Rebech G, Freitas J, Santos M, Costa S, Eug xea nio F, et al. miRNA-21 regulates CD69 and IL-10 expression in canine leishmaniasis. PLoS ONE. 2022;17:e0265192 pubmed publisher
Abbott J, Chan S, MacBeth M, Crooks J, Hancock C, Knight V, et al. Fluctuations in quality of life and immune responses during intravenous immunoglobulin infusion cycles. PLoS ONE. 2022;17:e0265852 pubmed publisher
Verde M, Villanueva Saz S, Loste A, Marteles D, Pereboom D, Conde T, et al. Comparison of circulating CD4+, CD8+ lymphocytes and cytokine profiles between dogs with atopic dermatitis and healthy dogs. Res Vet Sci. 2022;145:13-20 pubmed publisher
Amorim R, Clark K, Walker N, Kumar P, Herout K, Borjesson D, et al. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease. Stem Cell Res Ther. 2020;11:304 pubmed publisher
Wheat W, Chow L, Kuzmik A, Soontararak S, Kurihara J, Lappin M, et al. Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs. BMC Vet Res. 2019;15:330 pubmed publisher
Oliveira Silva K, Marin Chiku V, Luvizotto Venturin G, Correa Leal A, de Almeida B, de Rezende Eugênio F, et al. PD-1 and PD-L1 regulate cellular immunity in canine visceral leishmaniasis. Comp Immunol Microbiol Infect Dis. 2019;62:76-87 pubmed publisher
Yang H, Kim W, Bae J, Kim H, Kim S, Choi J, et al. Effects of irradiation and leukoreduction on down-regulation of CXCL-8 and storage lesion in stored canine whole blood. J Vet Sci. 2019;20:72-78 pubmed publisher
Ichiki T, Huntley B, Harty G, Sangaralingham S, Burnett J. Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling. Physiol Rep. 2017;5: pubmed publisher
Wheat W, Chow L, Kurihara J, Regan D, Coy J, WEBB T, et al. Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory Cytokine Release by Mesenchymal Stem Cells Occurs Through Multiple Distinct Biochemical Pathways. Stem Cells Dev. 2017;26:249-262 pubmed publisher
Resende L, Aguiar Soares R, Gama Ker H, Roatt B, Mendonça L, Alves M, et al. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge. PLoS ONE. 2016;11:e0161169 pubmed publisher
MacDiarmid J, Langova V, Bailey D, Pattison S, Pattison S, Christensen N, et al. Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model. PLoS ONE. 2016;11:e0151832 pubmed publisher
Shahbazi M, Zahedifard F, Taheri T, Taslimi Y, Jamshidi S, Shirian S, et al. Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis. PLoS ONE. 2015;10:e0132794 pubmed publisher
Costa Pereira C, Moreira M, Soares R, Marteleto B, Ribeiro V, França Dias M, et al. One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis. BMC Vet Res. 2015;11:92 pubmed publisher
Figueiredo M, Deoti B, Amorim I, Pinto A, Moraes A, Carvalho C, et al. Expression of regulatory T cells in jejunum, colon, and cervical and mesenteric lymph nodes of dogs naturally infected with Leishmania infantum. Infect Immun. 2014;82:3704-12 pubmed publisher
product information
master code :
DY1507
SKU :
DY1507
product name :
Canine TNF-alpha DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Canine TNF-alpha DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies canine TNF-alpha.
target :
TNF-alpha
category :
ELISAs
species :
Canine
gene symbol :
TNF
kit type :
Solid Phase Sandwich ELISA
elisaRange :
15.60 - 1000 pg/mL
top caption :
Canine TNF-alpha ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
APC1 protein, Cachectin, Cachetin, DIF, TNF, TNF, monocyte-derived, TNF-a, TNFA, TNFalpha, TNF-alphacachectin, TNFATNF, macrophage-derived, TNFG1F, TNFSF1A, TNFSF2, TNFSF2TNF superfamily, member 2, tumor necrosis factor, tumor necrosis factor (TNF superfamily, member 2), tumor necrosis factor alpha, Tumor necrosis factor ligand superfamily member 2, tumor necrosis factor-alpha
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.